This site is intended for healthcare professionals only
The government’s proposal to expand naloxone accessibility to OTC ran from January 24 2024 to March 6 2024. It marks a commendable effort to address the opioid crisis, says C+D’s Nana Ofori-Atta.
The government is seeking to expand the availability of naloxone without a prescription to include pharmacies. This would make the medication further accessible to individuals who are at risk of opioid overdose.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…
I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.
Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.
How has the role of a pharmacy technician been professionalised, and what's their place within community pharmacy’s future?
C+D’s annual Salary Survey covers many angles, but of course your salary is one of them. Are you getting the satisfaction you need?
